ATYR PHARMA INC (ATYR)
US0021202025 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ATYR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.4. This target is 520.06% above the current price.
ATYR was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ATYR.
In the previous month the buy percentage consensus was at a similar level.
ATYR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-06 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-04 | Wells Fargo | Initiate | Overweight |
| 2024-09-05 | Jefferies | Initiate | Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |